Blanchard, T.G.; Czinn, S.J.; Banerjee, V.; Sharda, N.; Bafford, A.C.; Mubariz, F.; Morozov, D.; Passaniti, A.; Ahmed, H.; Banerjee, A.
Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer. Cancers 2019, 11, 199.
https://doi.org/10.3390/cancers11020199
AMA Style
Blanchard TG, Czinn SJ, Banerjee V, Sharda N, Bafford AC, Mubariz F, Morozov D, Passaniti A, Ahmed H, Banerjee A.
Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer. Cancers. 2019; 11(2):199.
https://doi.org/10.3390/cancers11020199
Chicago/Turabian Style
Blanchard, Thomas G., Steven J. Czinn, Vivekjyoti Banerjee, Neha Sharda, Andrea C. Bafford, Fahad Mubariz, Dennis Morozov, Antonino Passaniti, Hafiz Ahmed, and Aditi Banerjee.
2019. "Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer" Cancers 11, no. 2: 199.
https://doi.org/10.3390/cancers11020199
APA Style
Blanchard, T. G., Czinn, S. J., Banerjee, V., Sharda, N., Bafford, A. C., Mubariz, F., Morozov, D., Passaniti, A., Ahmed, H., & Banerjee, A.
(2019). Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer. Cancers, 11(2), 199.
https://doi.org/10.3390/cancers11020199